1. Antiretroviral treatment of maternal HIV infection.
- Author
-
Talaie H, Nava-Ocampo AA, and Koren G
- Subjects
- Canada, Female, HIV Infections transmission, HIV-1, Humans, Infant, Newborn, Pregnancy, Risk Factors, Women's Health, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV Infections prevention & control, Infectious Disease Transmission, Vertical prevention & control, Pregnancy Complications, Infectious drug therapy, Pregnancy Complications, Infectious virology
- Abstract
Question: One of my pregnant patients tested positive for human immunodeficiency virus. Will HIV therapy put her pregnancy outcome at risk?, Answer: The biggest risk is vertical transmission of HIV to her baby. She should be treated with combination therapy; triple therapy is required to reduce vertical transmission. Zidovudine is not teratogenic in humans, but information on other antiretroviral drugs is incomplete.
- Published
- 2004